CDKN2A and glomerulosclerosis: In the context of aging, senescent cell depletion through the INK-ATTAC transgene that removes p16(Ink4a)-positive senescent cells upon drug treatment, leads to attenuated glomerulosclerosis and lower blood urea nitrogen levels later in life (Baker et al. 2016).